Boston Scientific


In The Know: December 6, 2018

December 6, 2018 | Tags: , , , , , , , , , , , , , , , , ,

Nearly 150 groups join AdvaMed’s anti medtech tax letter

Inspire Medical offers another 1.5 million shares following April IPO

 

POPS! Diabetes Care Announces FDA Clearance of Their POPS!® one System

 

NxThera spinout NxPhase lands $10m for vapor ablation tech

 

Mayo Clinic Startup Phenomix Sciences Initiates $1M Seed Funding Round

 

IPM Earns 2018 Malcolm Baldrige National Quality Award

 

“First, do no harm” calls for thoughtful physician-patient dialogue, not fear

 

Tabula Rasa HealthCare to Acquire DoseMe, a Precision Dosing Software Company

 

Hospital Infections Kill 99,000 Americans Every Year. Are Giant Roombas the Solution?

 

Medtronic studies use of both heat and cold for cardiac ablation

Monteris Medical scores reimbursement win with Aetna

 

Osprey awarded purchasing agreement for DyeVert PLUS

 

Mayo researchers say oral apixaban safe and effective for treating blood clots in cancer patients

 

Spineology Inc. Announces New Board Members

 

Former UnitedHealth, Best Buy exec Nyman joins MN Blue Cross parent

 

OneOme Receives License to Offer its Comprehensive Pharmacogenomic Test in New York State

 

Inspire Medical Systems, Inc. Announces Publication of Data From ADHERE Registry

 


In The Know: Minnesota’s Healthcare News for November 29, 2018

November 28, 2018 | Tags: , , , , , , , , , , , , , , , , , , ,

Boston Scientific Announces Recommended Offer to Acquire BTG plc.

 

HHS Deputy Secretary Hargan Announces DSIIS Participants and First Meeting Date

 

Medtronic to Acquire Nutrino Health

 

Biotech company DiaMedica sets IPO terms to rake in up to $20M

 

Confirm Rx: PopSci’s ‘Best of 2018’

 

Bracelets That Help Kick Bad Habits

ANI Pharmaceuticals, Inc. Ranked Number 366 Fastest Growing Company in North America on Deloitte’s 2018 Technology Fast 500™

 

Cantel Medical To Acquire Omnia For Europe Expansion

 

2018 CFO of the Year: Brian Mower, Medibio

 

Farm animals may soon get new features through gene editing

 

Blue Cross CEO Craig Samitt wants to be a disruptor for health care; here’s what that means for the Blues

 

Admedus reports $6.3 million revenues amid $12.7 million Star Bright backing

 

For Mayo scientist, spinal-injury research is personal

In the Fight Against Cancer, Sleeping Beauty Awakens

 

NHS clinical trial could pave the way for new depression treatment

 

NeuroOne Medical Technologies Corporation Announces Appointments to Artificial Intelligence Advisory Board

 

Mainstay Medical announces headline results from ReActiv8-B clinical study

Mayo partnership aims to teach digital stethoscope to detect heart trouble

Pursuit Vascular Announces Patent Notice of Allowance for its ClearGuard HD Antimicrobial Barrier Caps

 

Hill-Rom announces executive appointments

 

Our View: Mayo Clinic’s growth is good news for Rochester and state


Top Healthcare News for November 8, 2018: In the Know

November 7, 2018 | Tags: , , , , , , , , , , , , , , , ,

Governor Dayton Proclaims “Earl Bakken Day” in Minnesota

NeoChord raises $25m in Series D

Fairview Launches Innovative Workplace Behavioral Health Service for Employers

CardioMech Appoints Richard Nehm as President and CEO, and Mark Novotny as Chairman

With new FDA clearance, Abbott Freestyle Libre users can ditch handheld readers for an app

Eight New Operating Rooms Opening At Mayo Mankato

Medtronic touts five-year data for In.Pact Admiral drug-coated balloon

Boston Scientific’s Eluvia drug-eluting stent succeeds in long lesions

Lars Rasmussen steps down as CEO of Coloplast A/S

Democrats flip medtech-heavy Minnesota House seats

Trump’s trade war and the midterms: Views from two Heartland districts

CMS Grants Outpatient Pass-through Payment to the remedē® System for the Treatment of Central Sleep Apnea

FDA, DoD formalize medical product development deal

Adhesive Innovation Helps Clinicians Confidently Meet the Most Challenging Demands of Critical Tube Securement

ProMed to host 30th anniversary open house

ANI Pharmaceuticals Reports Third Quarter and Year-To-Date 2018 Results and Reaffirms Guidance

Medical Device Startup HeartHero Announces Agreement With Vivaquant

Cool Offices: Bright Research aims for ‘hip’ style in downtown space

Tigger Is a Puppy With Prosthetics — And He’s About To Help Kids With Prosthetics, Too! (*Tear*)

 


Top Healthcare News for October 25, 2018: In The Know

October 24, 2018 | Tags: , , , , , , , ,

Boston Scientific posts better-than-expected earnings

 

 

The Journey: What ever happened to the ‘health dividend’?

 

 

Where and What is Medical Alley? It’s the Silicon Valley for digital health and med-tech companies.

 

 

Prevent Biometrics® Acquires Assets of X2 Biosystems, Consolidating Leadership in Head Impact Monitoring

 

 

SpineThera Acquired to Expand Non-Opioid Pain Management Portfolio

 

 

University of Minnesota Partners with Canadian Startup to Advance Development of Alzheimer’s Detection Tech

 

 

Medtech issues again take center stage in Minn. Congressional races

 

 

Tactile Medical Announces License Agreement for Certain Intellectual Property of Sun Scientific, Inc.

Heraeus Medical facilitates hospital-patient interaction with new digital solution

 

 

Upsher-Smith Launches Generic Version Of Onfi® (clobazam), CIV In Tablet And Oral Suspension Dosage Forms

Humanetics Corporation to Present at the Annual Meeting of the American Society for Radiation Oncology

 


6 Questions on the Future of Healthcare with Bright Health’s Kyle Rolfing

October 22, 2018 | Tags: , , , , , , , , , , , , ,

6 Questions is a new interview series with Medical Alley leaders on the future of healthcare. Medical Alley Association’s membership includes leaders in healthcare delivery, payment, technology, and policy, which gives us – and in turn, you – access to diverse perspectives on how healthcare is changing and what lies ahead.

Medical Alley is the global epicenter of health innovation and care; 6 Questions, is meant to share insights and spark discussion. If you have a perspective on the future of healthcare, feel free to share it by reaching out to Frank Jaskulke, Vice President of Intelligence at fjaskulke@medicalalley.org

This interview with Kyle Rolfing, President & Co-Founder of Bright Health, has been lightly edited for clarity and length.To see more, click the button below.

6 Questions Series

 

Will the future of healthcare be most significantly defined by reigning in costs or accelerating outcomes? 

Both, and the key to both reigning in costs and improving outcomes will be addressing waste and redundancy. That’s one of the things we’re most proud about at Bright Health. Addressing waste and redundancy is at the center of the Bright Health Care Partner Health Plan model.  By partnering with one health system per market, we are able to streamline the process of approvals and referrals, reduce duplicate and/or unnecessary testing, and ultimately enhance our providers’ ability to deliver coordinated care across their systems. This next generation health plan cuts down on time and money while also delivering better healthcare.

What is the definition of value in healthcare today and what should it be?

In any other industry, value is defined by the consumer. In healthcare that hasn’t been the case for a long time. Consumers should be defining value in healthcare like any other industry, and we are beginning to see a shift in that direction.

For example, we know that affordability is a huge issue for consumers and healthcare is simply not affordable for many of them.  In addition, for the cost they are paying, they expect to have high quality, convenient service, and our fragmented healthcare system is a long way from delivering that. But there are signs we are headed in the right direction – finding ways to provide high-quality, more affordable healthcare to the majority of hard-working Americans is our priority #1 at Bright Health.

What’s the biggest “blind spot” in healthcare today?

The biggest “blind spot” is the lack of focus on the consumer as the customer. The fee-for-service relationship between payers and providers results in fragmented care that treats pieces and parts rather than the whole person.

Value-based care, which is the goal of the Bright Health model, does treat the whole person, optimizes health outcomes and is critical to redefining the system as consumer-centric.

What’s your company’s or sector’s biggest “blind spot?”

This answer is the same as above, and it captures why Bright Health is pioneering a new Care Partner Health Plan model. By working with one health system in each market, we remove the friction that has traditionally existed between payers and providers, resulting in an integrated, streamlined experience for the consumer.

Why is a presence in Medical Alley, critical to your company?

Talent is the most important factor in success. Our decision to be headquartered in Minneapolis was intentional because of the immense healthcare talent that exists here. Minnesota has healthcare industry leaders like Medtronic, Mayo Clinic, United Healthcare, and Boston Scientific, among others. In addition, you have companies like General Mills and Target who are at the intersection of healthcare and the consumer. Given the focus of our company – on providing the best consumer healthcare experience – we think being able to draw from these talent pools has been a huge contributor to our early success.

What is the one thing, other than time or money, you wish you had more of?

Speed. We have been fortunate with the great talent we’ve been able to attract as well as the strength of our Care Partners. This combination has allowed us to prove that our model works out of the gate. As a result, we’ve been able to attract top investors and have access to plenty of capital: we expanded from 1 market to 3 in the first year and are adding 12 new markets this year. But we really want to get this solution out to as many consumers as quickly as we can because we know it’s so needed in the marketplace.

Learn more about Bright Health by visiting their website at brighthealthplan.com

 

Curious About Value-Based Care?

Attend the November 6th Leading the Conversation: Value-Based Care, taking place at The Hutton House in Minneapolis, MN.

Learn More & Register

In The Know: Top Healthcare News For October 18, 2018

October 18, 2018 | Tags: , , , , , , , , , , , , , , , ,

Pops! Diabetes Makes Pepperdine Graziadio Business School’s Most Fundable Companies List

 

 

Where medtech is putting its money this November

 

On the sidelines of Startup Week: ‘Fly-ins’ get a $300 offer to check out the job scene

 

Boston Scientific touts 3-year Solyx stress urinary incontinence mesh trial data

 

Twin Cities Startup Week isn’t just for startups

 

Heart Center Dresden to Be First Commercial Clinical Site for Imricor

 

How do you make doctors trust machines in an AI-driven clinical world?

 

Celcuity Announces Clinical Trial Collaboration with Puma Biotechnology and West Cancer Center

 

Medtronic launches workflow system to help wean patients off oral opioids

3 ways HHS can help medtech innovators

 

Baxter, Mayo team up on outpatient kidney care center

 

Reemo Health and HNC Virtual Solutions Announce Transformative Connected Health Solution for Healthy Aging

 

What can healthcare learn from cable? A closer look at the Comcast – Independence joint venture

 

ANI Announces Launch of Authorized Generic of Brethine®

 

OneOme and St. Catherine Specialty Hospital in Croatia Partner to Increase Access to Pharmacogenetic Testing in Europe

VivaQuant Inks Collaboration with FDA to Improve Accuracy of Drug Cardiac Safety Assessment

 

Bio-Techne Partners Micropoint Bioscience, Expands in China

 

Gene-edited beef could be coming to dinner plates around the globe

 

Latest iMedNet Release Improves Infrastructure, Scalability and User Experience


6 Questions with Noleus Technologies’ Dr. Swarna Balasubramaniam of gBETA Medtech

October 15, 2018 | Tags: , , , , , , , , ,

gener8tor, a nationally ranked accelerator program, has partnered with Boston Scientific to launch a healthcare-focused program in Medical Alley with additional support from the University of Minnesota and Mayo Clinic. Their first cohort wrapped up in June and the second cohort was announced in July.

Over the next few weeks, we will profile the second cohort of companies.

What does Noleus Technologies do?

Noleus designs and develops a disposable device that mitigates postoperative bowel swelling to accelerate patient recovery after abdominal surgery.

What difference does this make for patients?

Noleus will provide better patient care by addressing 1) faster bowel recovery, which means patients will be able to eat and drink sooner, and 2) earlier hospital discharge, thereby reducing the risk of hospital-acquired conditions.

What motivated you to take on this issue?

I have been frustrated by the problem of postoperative ileus (slow recovery of intestinal function) over the 20 years I have practiced as a colorectal surgeon. It leads to longer hospital stays and poorer outcomes. Recent developments have led to the understanding that the lack of bowel function is due to swelling. The opportunity to change the way we care for patients after abdominal surgery and improve outcomes is irresistible, and it drove me to develop this from an idea to early-stage start-up over 18 months.

What did you do before starting this company

I am a practicing board-certified colon & rectal surgeon with over 20 years of experience trained at the Mayo Clinic and the University of Southern California. I manage my own practice in addition to previously working in several other settings and am well versed in the business aspects of medicine in addition to clinical practice.

How can the Medical Alley community best support your work?

Medical Alley provides the right culture and ecosystem to bring together renowned clinicians and medical device experts to develop Noleus, a first-of-its-kind device.

And finally, Why participate in gBETA?

By partnering with gBETA, we develop a customized growth strategy for Noleus to ensure we deliver value efficiently and effectively to our customers. The program has an amazing network of experienced mentors that are essential in guiding and building Noleus.

About gBETA Medtech

gBETA Medtech is a free, seven-week accelerator that works with medical device, healthcare-related software, biotech and diagnostics startups. Part of gener8tor, a nationally ranked accelerator program, gBETA Medtech is in partnership with Boston Scientific and supported by the Mayo Clinic and the University of Minnesota. For more information visit https://www.gbetamedtech.com/

To learn more about Noleus Technologies visit Website: www.noleustechnologies.com 

Want to see all the gBETA cohort 2 companies’ demo? LiveBETA is October 10th – details here: https://livebetamedtechsummer2018.splashthat.com/


6 Questions with Morari’s Jeff Bennet of gBETA Medtech

October 7, 2018 | Tags: , , , , , , ,

gener8tor, a nationally ranked accelerator program, has partnered with Boston Scientific to launch a healthcare-focused program in Medical Alley with additional support from the University of Minnesota and Mayo Clinic. Their first cohort wrapped up in June and the second cohort was announced in July.

Over the next few weeks, we will profile the second cohort of companies.

 

What does Morari do?

Morari is an early-stage medical device company that is developing an external device for the treatment of premature ejaculation (PE). Grounded in basic science and clinical study research, the Morari concept is intended to be a transdermal-based product using neuromodulation as a means of inhibiting the nerves of the penis, thereby delaying an ejaculation.

What difference does this make for patients?

It restores confidence in male sexual health by eliminating the embarrassment and frustration of PE.

What motivated you to take on this issue?

PE is the most prevalent male sexual dysfunction, estimated to affect 30 percent of men worldwide. It has a higher incidence than erectile dysfunction or an enlarged prostate, yet men rarely talk about it or seek treatment. We hope to create awareness for this medical condition and provide a better treatment option.

What did you do before starting this company?

I served as the Director of Marketing at IMRIS. Overall, I have over 20 years of sales and marketing experience with Vysis/Abbott, Medtronic, American Medical Systems, Boston Scientific, and IMRIS.

How can the Medical Alley community best support your work?

Continue to support events that bring together experts in the field on medical devices that are willing to help others. Also, generating awareness of sexual health and forums that provide discussion on this topic will help the overall community be more accepting of these conversations.

And finally, why participate in gBETA?

Starting a company can be a very intimidating process for someone who has never done it before. Being a part of gBETA, you are in an environment with others in the same position. These companies and individuals are a great resource for support and ideas on how to succeed. Also, the gBETA team has worked with hundreds of companies and can offer tips and tricks on what works and what doesn’t.

About gBETA Medtech

gBETA Medtech is a free, seven-week accelerator that works with medical device, healthcare-related software, biotech and diagnostics startups. Part of gener8tor, a nationally ranked accelerator program, gBETA Medtech is in partnership with Boston Scientific and supported by the Mayo Clinic and the University of Minnesota. For more information visit https://www.gbetamedtech.com/

To learn more about Morari visit www.morarimedical.com

Want to see all the gBETA cohort 2 companies’ demo? LiveBETA is October 10th – details here: https://livebetamedtechsummer2018.splashthat.com/


6 Questions with Lucia Health Guidelines’ Dr. Gil Ungab of gBETA Medtech

October 1, 2018 | Tags: , , , , , , ,

gener8tor, a nationally ranked accelerator program, has partnered with Boston Scientific to launch a healthcare-focused program in Medical Alley with additional support from the University of Minnesota and Mayo Clinic. Their first cohort wrapped up about a month ago and the second cohort was announced on in July.

Over the next few weeks, we will profile the second cohort of companies.

What does Lucia Health Guidelines do?

Lucia Health Guidelines has created a clinical decision support tool that leverages machine learning and the power of cloud computing to help maintain clinical guidelines at the point of care. Lucia is initially focused on Atrial Fibrillation (AFib) and ensuring proper treatment in the Emergency Department. Lucia’s technology will provide all clinicians a tool to confidently identify AFib on EKG and initiate guideline-recommended treatment to prevent strokes.

What difference does this make for patients?

By getting patients on a proper treatment plan when AFib is first encountered we hope to prevent the devastating outcome of a stroke. A study last year by Dr. Xian of Duke University found that 58,000 to 88,000 strokes per year could be prevented by appropriately following guidelines.

What motivated you to take on this issue?

My father had a stroke from undiagnosed AFib. His strength and courage in dealing with his disability inspired me to become a Cardiac Electrophysiologist. I know firsthand how catastrophic a stroke can be for the patient and the whole family.

What did you do before starting this company?

I am a private practice Cardiac Electrophysiologist in San Diego, California. I have served on R&D advisory boards for many of the major device companies. I helped local San Diego healthcare startups and then co-founded my first healthcare software startup a few years ago.

How can the Medical Alley community best support your work?

Our healthcare system is complex, and I don’t always have the answer to my questions. An organization like yours provides the right resources for navigating that complexity and connecting to those willing to help. My time spent working with and visiting the device companies over the years has shown me what a great community exists in the Twin Cities area.

And finally, why participate in gBETA?

I did not participate in an accelerator with my first startup. There is so much more I can learn from a program like gBETA and the mentorship they provide.

About gBETA Medtech

gBETA Medtech is a free, seven-week accelerator that works with medical device, healthcare-related software, biotech and diagnostics startups. Part of gener8tor, a nationally ranked accelerator program, gBETA Medtech is in partnership with Boston Scientific and supported by the Mayo Clinic and the University of Minnesota. For more information visit https://www.gbetamedtech.com/

 

To learn more about Lucia Health Guidelines visit: www.luciaguidelines.com

Want to see all the gBETA cohort 2 companies’ demo? LiveBETA is October 10th – details here: https://livebetamedtechsummer2018.splashthat.com/


September 27, 2018: In The Know

September 26, 2018 | Tags: , , , , , ,

Medtronic is all-in on surgical robotics with $1.6B Mazor buy

Implant, intense rehab help 3 paralyzed for years take steps

Boston Scientific wins FDA nod for drug-eluting vascular stent

Aria CV Wins TCT 2018 Shark Tank Competition

Medtronic launches Infinity OCT spinal system

Ken Burns shares the story of Mayo Clinic on ‘Late Night with Seth Meyers’

Premier Biotech’s OralTox® Testing Device Granted the First-Ever FDA Clearance for the Detection of Oxycodone in Oral Fluid; 8 Drug Panel Now 510(k) Cleared

Boston Scientific, Medtronic tout stent trial results

Electromed, Inc. Announces Fiscal 2018 Fourth Quarter Financial Results

CDRH, MDIC Look to Global Application for NEST

Medtronic seeks to patent color-changing skin patch to measure glucose in sweat

 


Keep your finger on the pulse of Medical Alley from anywhere with the ALLEY NEWSLETTER